Aspirin resistance in patients with acute coronary syndrome. Part 1

Aspirin resistance in patients with acute coronary syndrome. Part 1

Aim. To evaluate the prevalence of aspirin resistance, its clinical features, potential solutions, and prognostic role in patients with acute coronary syndrome (ACS). Material and methods. The study included 51 patients with ACS and ST segment elevation (STEACS) and 49 ACS patients without ST segmen...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. S. Frolova, R. M. Shakhnovich, E. M. Kaznacheeva, O. V. Sirotkina, A. B. Dobrovolsky
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2010-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	acetylsalicylic acid aspirin resistance acute coronary syndrome platelet aggregation inflammation markers genetic polymorphisms
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2143
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Aspirin resistance in patients with acute coronary syndrome. Part 2
by: N. S. Frolova, et al.
Published: (2011-04-01)

Comparison of farmacodynamic properties of three different aspirin formualtions in patients with stable coronary disease
by: Antić Ana, et al.
Published: (2019-01-01)

Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry
by: Kevin P. Bliden, et al.
Published: (2024-12-01)

HEMOSTASIS AND FUNCTIONAL PROPERTIES OF NEUTROPHILS IN PATIENTS WITH VARIOUS SENSITIVITY TO ACETYLSALICYLIC ACID IN ACUTE CORONARY SYNDROME
by: I. Yu. Grinshtein, et al.
Published: (2015-10-01)

ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: D. H. Ainetdinova, et al.
Published: (2016-01-01)

Aspirin Intolerance in the Setting of Acute Coronary Syndrome: Case Report and Review of Literature
by: Temirbek Janpaizov, et al.
Published: (2025-04-01)

ASPIRIN RESISTANCE CANDIDATE GENES AND THEIR ASSOCIATION WITH THE RISK OF CARDIOVASCULAR EVENTS
by: Yu. I. Grinshtein, et al.
Published: (2013-02-01)

Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome
by: I. Yu. Grinshtein, et al.
Published: (2016-11-01)

Antiaggregant influence on platelet aggregation in patients with acute coronary syndrome without ST segment elevation
by: T. M. Poponina, et al.
Published: (2006-10-01)

Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome
by: Wenbo Dai, et al.
Published: (2025-07-01)

Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease
by: M. D. Goncharov, et al.
Published: (2021-03-01)

COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE
by: N. A. Belolipetskiy, et al.
Published: (2016-01-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)

Aspirin-induced gastrointestinal lesions in patients with chronic coronary artery disease: special aspects and therapeutic options
by: N. Yu. Borovkova, et al.
Published: (2020-04-01)

Efficacy of buffered and enteric-coated acetylsalicylic acid on platelet aggregation in patients with stable coronary artery disease and type 2 diabetes (CASCADE): rationale and design of a single-center observational comparative study
by: Zh. D. Kobalava, et al.
Published: (2025-02-01)

The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention
by: Wen-Bo Dai, et al.
Published: (2024-12-01)

DYNAMICS OF HEMOSTASIS AND NEUTROPHIL FUNCTIONAL ACTIVITY CHANGES IN PATIENTS WITH VARIOUS SENSITIVITY TO ACETYLSALICYLIC ACID IN ACUTE MYOCARDIAL INFARCTION
by: I. Yu. Grinshtein, et al.
Published: (2016-08-01)

ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE
by: M. G. Bubnova
Published: (2010-08-01)

Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology
by: M. M. Tanashyan, et al.
Published: (2021-09-01)

Possibility of application of low-frequency piezothromboelastografy method for the evaluation of haemostatic potential of blood in coronary bypass surgery on the background of long aspirinotherapy
by: Elena V. Fanaskova, et al.
Published: (2017-10-01)

Effect of aspirin dosage on oxidative stress and platelet reactivity in patients undergoing coronary artery bypass grafting (APRICOT): randomized controlled trial
by: Aleksandra Gąsecka, et al.
Published: (2025-12-01)

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN
by: A. I. Martynov, et al.
Published: (2015-09-01)

EVALUATION OF ASPIRIN USAGE SAFETY IN CORONARY BYPASS SURGERY
by: A. M. Chernyavsky, et al.
Published: (2017-10-01)

Platelets in preeclampsia: an observational study of indices associated with aspirin nonresponsiveness, activation and transcriptional landscape
by: Gashaw Garedew Woldeamanuel, et al.
Published: (2025-06-01)

Double antiplatelet therapy in patients with acute coronary syndrome
by: A. V. Rodionov, et al.
Published: (2011-10-01)

Efficacy of buffered acetylsalicylic acid and enteric-coated acetylsalicylic acid on platelet aggregation in patients with chronic coronary syndrome and type 2 diabetes (CASCADE): single-center observational comparative study
by: Zh. D. Kobalava, et al.
Published: (2025-03-01)

ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID
by: I. N. Bokarev, et al.
Published: (2016-01-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

Genetic predictors of five-year outcomes of acute coronary syndrome
by: N. G. Lozhkina, et al.
Published: (2019-11-01)

GENETIC MARKERS OF NEGATIVE OUTCOMES OF THE ACUTE CORONARY SYNDROME
by: N. G. Lozhkina, et al.
Published: (2014-10-01)

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
by: P. J. Dovgalevsky, et al.
Published: (2016-01-01)

Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery
by: A. A. Kosinova, et al.
Published: (2019-07-01)

The effect of single and dual antiplatelet therapy on the activity of pro-inflammatory cytokines in patients with coronary artery disease and obstructive sleep apnea
by: V. I. Ruzov, et al.
Published: (2020-04-01)

Impact of pharmacogenetics on aspirin resistance: a systematic review
by: Gustavo Figueiredo da Silva, et al.
Published: (2023-01-01)

SOME ASPECTS OF IMPROVING ADHERENCE TO DUAL ANTITHROMBOTIC THERAPY AFTER ACUTE CORONARY SYNDROME
by: A. D. Erlikh
Published: (2017-05-01)

Study of pharmaceutical properties of low-dosage enteric-coated acetylsalicylic acid
by: V. V. Rafalsky, et al.
Published: (2016-02-01)

Molecular and metabolic characteristics of changes in the platelet sensitivity to antiplatelet therapy in patients with coronary artery disease before and after coronary artery bypass grafting
by: M. D. Goncharov, et al.
Published: (2021-07-01)

CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION
by: N. V. Teplova
Published: (2016-03-01)

Aspirin-induced hepatotoxicity and anemia in children with acute rheumatic fever
by: Derya Altay, et al.
Published: (2021-04-01)

Advanced Subclinical Atherosclerosis and Low-Dose Aspirin
by: Michael J. Blaha, MD, MPH, et al.
Published: (2025-07-01)